ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan 
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
PLEASANTON, Calif., Nov. 14, 2017 -- The Cooper Companies, Inc. (NYSE:COO) will present at the BMO Prescriptions for Success Healthcare Conference in New York, NY, on December 14, 2017. Daniel G. McBride, Esq, Executive Vice President, Chief Operating Officer & President of CooperVision, Inc., will represent the Company in a presentation scheduled to begin at 1:30 PM ET.
A live audio webcast of the presentation will be available on the Investor Relations section of the Company's website at http://investor.coopercos.com.
About The Cooper Companies
The Cooper Companies, Inc. ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper is dedicated to being A Quality of Life Company™ with a focus on delivering shareholder value. Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of families with its diversified portfolio of products and services focusing on women’s health, fertility and diagnostics. Headquartered in Pleasanton, CA, Cooper has more than 10,000 employees with products sold in over 100 countries. For more information, please visit www.coopercos.com.
COO-G
Source: The Cooper Companies, Inc.
CONTACT:
Kim Duncan
Vice President, Investor Relations
[email protected]
